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ORIGINAL ARTICLE 
ELECTROPHYSIOLOGICAL CHANGES IN PATIENTS WITH LIVER 
CIRRHOSIS IN A TERTIARY CARE HOSPITAL IN KARACHI, PAKISTAN 
Om Parkash, Ghulam Rehman Mohyuddin*, Adil Ayub*, Irfan Nazir*, Arslan Arif 
Maan*, Saeed Hamid 
Department of Medicine, Section of Gastroenterology, *Medical Student, Aga Khan University Hospital, Karachi-Pakistan 
Background: Electrophysiological changes in cirrhosis are well known but least investigated 
especially in our country hence we wanted to see electrophysiological changes especially QT interval in 
cirrhotic patients. Methods: A cross-sectional study was conducted at Aga Khan University Hospital 
Karachi (AKUH) in which medical records (duration 2008–2010) of cirrhotic patients were reviewed. 
Results: Three hundred and eighty cirrhotic patients’ charts were studied, 227 (59.7 %) were male and 
mean age of this cohort was 52.8±12.6 years. The most common cause for CLD was Hepatitis C 
(CHC) in 260 (68.4%), NBNC in 56(14.7%) and HBV in 51 (13.4%). Only 225 had complete ECG 
workup, the mean corrected QT interval was 0.44±0.067sec. Among the electrophysiological 
abnormalities, 79 (35%) had a prolonged corrected QT interval, 7 (3.1%) had a prolonged PR interval 
(>0.22s) and prolonged QRS duration was seen in 23 (10.4%) patients. QT prolongation was seen in 1 
of the 5 patients with Child Class A (20%), 22 of the 73 patients with Child Class B (30.1%), and 25 of 
the 61 patients with Child Class C (41%). However, this difference however was not statistically 
significant. (p-value=.331). Conclusion: We conclude that QT prolongation is more frequent in 
patients with liver cirrhosis especially when the disease is more advanced like in Child C hence these 
patients are more prone to sudden cardiac death. Moreover, this study shows that the risk associated 
with QT prolongation is present through all classes of liver cirrhosis. We recommend that routine 
cardiac screening with ECG of all cirrhotic patients be performed. 
Keywords: Cirrhosis; QT interval; child class 
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INTRODUCTION  
Cirrhosis represents a late stage of progressive 
hepatic fibrosis characterized by distortion of the 
hepatic architecture and the formation of 
regenerative nodules. It is generally considered to 
be irreversible if patients decompensate at which 
point the only option may be liver transplantation.1 
Cirrhosis can be complicated by many conditions 
like upper gastrointestinal bleeding due to 
oesophageal varices (EV), hepatic 
encephalopathy(HE), Ascites with Spontaneous 
bacterial peritonitis (SBP) and renal impairment.2 
Cardiac electrophysiological abnormalities are 
well known entities in liver cirrhosis.  
Q-T interval prolongation is the most 
common abnormality in all electrophysiological 
abnormalities. Q-T interval represents ventricular 
electrical systole which is the repolarization 
phase.3,4 Its prolongation provokes very sinister 
ventricular arrhythmias that can cause sudden 
death.5 This is probably caused by a functional 
defect as this is reversed after liver 
transplantation.6 QT interval duration can be 
determined by conventional 12 lead 
electrocardiographic (ECG) recording from the 
onset of the QRS complex to the end of the T 
wave. QT interval varies with heart rate, it 
decreases when heart rate accelerates.3 Therefore 
corrected QT interval is used for the measurement. 
Initially prolonged QT interval along with increased 
sudden deaths was identified in alcoholic cirrhotic 
patients7 and then subsequently in cirrhosis of different 
aetiologies along with the severity of disease.5 In 
cirrhosis, prolonged Q–T interval is significantly related 
to the severity of the liver disease, portal hypertension, 
portosystemic shunts and reduced survival.8,3 However 
prolonged QT interval can also be seen in well 
compensated liver disease.9 It is estimated that 
prevalence of  this abnormality in Child Pugh Class A is 
25%10, 51% in CTP class B and 60% in CTP Class C5.  
Similarly, a study from Pakistan had also 
shown the higher frequency of prolonged QT 
interval but on smaller number of patients. That 
study had shown mean QTc of the cirrhotic group 
was 0.438±0.015 sec and that of the non-cirrhotic 
group was 0.432±0.010 sec. The heart rate for the 
cirrhotic group was 78.34±12.15 and for the non-
cirrhotic group was 74.98±8.03 b/min respectively. 
The mean QTc and HR values were significantly 
more in the cirrhotic group as compared to the non-
cirrhotic with p=0.006 and p=0.043 respectively.11 
Our study aims to further add to this topic, by using a 
larger sample size and wanted to look for 
electrophysiological abnormalities like QT interval, 
PR interval and QRS complex. This topic is poorly 
researched in Pakistan. 
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MATERIAL AND METHODS   
This was a cross-sectional study on medical records 
of all patients with known cirrhosis coming in a two 
year period (2008–2010) at the Aga Khan University, 
Karachi, Pakistan. 
Charts of all established cirrhotic patients of 
any aetiology (viral as well as non-viral associated 
cirrhosis) were included. The diagnosis of cirrhosis 
was made on clinical basis, i.e., history of ascites, 
upper gastro-intestinal bleed, encephalopathy and 
ultrasound showing features of cirrhosis like  
shrunken liver, dilated portal vein, splenomegaly etc. 
Patients who were known cases of ischemic 
heart disease, Renal failure, Hypertension (HTN), 
bundle branch block (BBB) and patients taking drugs 
which prolong Q-T interval such as Sotalol and 
disopyramide, patient with electrolyte abnormalities 
such Hypokalaemia, Hypocalcaemia, 
Hypomagnsemia and patients with chronic 
obstructive pulmonary disease were excluded. 
Ethical approval was taken from the 
Departmental Ethical Committee and the data was 
collected on predesigned pro forma. In all our 
patients, standard 12 lead ECG was done by the 
senior technician in the electrocardiographic 
department. Manual QT interval was measured and 
then corrected QT (QTc) was calculated by formula: 
 (QTc=QTinterval/ ervalRR int ). 
The normal upper limit cut off value for 
QTc is 440 mili seconds (ms). Currently modern 12 
leads ECG gives the calculated value of QT and QTc 
while it can also be manually measured when all 12 
leads are simultaneously recorded.3 
The data was analysed using SPSS 19.0. P 
value for difference between QT prolongation in beta 
blocker and non-beta blocker group was 0.15. The p 
value for differences between QT prolongations as 
we moved from Child class A to C was 0.33.  
The effect of beta blocker use on QT 
interval in the study sample of 225 patients with a 
complete record was analysed using Pearson’s chi 
squared test.  
RESULTS 
A total of 380 patients with CLD were admitted; out 
of which 225 patients had ECG record available. The 
mean age of this cohort was 52.8±12.6 years.  
The QT interval was calculated for a total of 
225 patients with a minimum of .20 ms, maximum of 
.52 ms and a mean of .3682, with the standard 
deviation being .05423. The QRS complex was 
calculated for 225 patients with a minimum of .02 
ms, maximum of .48ms and a mean of .086±0.03. 
The PR interval was analysed in 225 patients, and 
ranged from 0 to .26 ms, with a mean of 0.15±0.03. 
The mean pulse calculated from 341 patients was 
88.58±19. 
Electrophysiological changes showed mean 
QT interval was 0.37±0.05ms, mean QRS 
0.086±0.054, PR interval 0.15±0.03.  
Most common electrophysiological 
abnormality was prolonged QT interval in 79 
(35.1%) patients and 23 (10.4%) had prolonged QRS 
complex. 
A total of 139 patients had complete child 
scoring and ECG performed. 
Out of these 139 patients, 5 were in child 
class A. One out of these 5 patients showed a QT 
prolongation, none showed PR abnormalities and 1 
had QRS prolongation. 
Out of the 73 patients in class B, 41 (30.1%) 
showed QT interval prolongation, 5.5% showed PR 
abnormalities and 9.7% showed QRS complex 
abnormalities 
From the 61 cases in class C for whom a 
complete record was available, 41% had QT interval 
prolongation, 4.9% had PR abnormalities and 11.9% 
had QRS abnormalities.  
The effect of beta blocker use on QT 
interval was also performed using corrected QT 
values. Out of the 225 patients with ECGs performed, 
76 used beta blockers and 149 did not. Out of the 76 
patients using beta blockers, 48(32.9% of the total 
cases with normal QT) had a QT interval that was 
normal (from 0 to .46), while 28 (35.4% of those with 
too long a QT) had a longer than normal QT interval. 
Amongst the 149 patients not using beta blockers, 98 
(67.1% of those with normal QT) had a QT interval 
that was normal.  The other 51 patients not using beta 
blockers had a prolonged QT, and these account for 
64.6% of the patients with a longer than normal QT 
interval.  
The effect of beta blocker use on QRS 
complex was also analysed among our study sample. 
Out of the 76 people using beta blockers, 36.8% had 
an abnormal QRS complex interval.  
Table-1: Baseline characteristics 
 n (%) 
Male  227(59.7) 
Cause of CLD 
HCV CLD 260 (68.4) 
HBV 51 (13.4) 
HBV/HDV 13 (3.4) 
NBNC CLD 56 (14.7) 
Child Class (n=228) 
A 8 (3.5) 
B 130 (57) 
C 90 (39.4) 
DISCUSSION 
This study had shown the higher frequency of 
electrophysiological abnormalities in patients with 
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cirrhosis. An electrophysiological abnormality in 
cirrhotic patients includes chronotropic 
incompetence; electromechanical uncoupling, and 
electrocardiographic QT interval prolongation. 
Their underlying mechanism is unknown but 
some of these have common alterations at molecular 
level.3  These mechanisms such as the sympathetic 
nervous activity influences the heart rate and 
electromechanical coupling by several mechanisms: 
Noradrenaline binding to B-receptors, receptor-
mediated G protein interaction and, consequently, 
stimulation of adenylcyclase, activation of cAMP-
dependent phosphokinase A and channel 
phosphorylation. Several receptor and post-receptor 
defects have been described in cirrhosis with reduced 
B-receptor density and sensitivity, and altered G 
protein and calcium channel functions. All these 
mechanisms are responsible for these 
electrophysiological abnormalities.2,3 
Our study did have much more males than 
females, a reflection of the unfortunate reality that 
men are much more frequently exposed to risk 
factors for hepatitis infection in Pakistan.12 
Our study showed a rising trend in the 
percentage of cases showing a QT prolongation (20–
30% to 41%) as we go from class A to C. Although a 
clearly higher percentage of patients had QT 
prolongation as we progressed from Class A to C, 
this difference however was not statistically 
significant. (p value=.331).  
The QT interval was not significantly 
different between the Beta Blocker and Non-blocker 
group (0.15 p value), proving that there is no 
significant effect of beta Blocker on QT prolongation 
in this cohort of patients. 
From the 149 patients not using beta 
blockers, 34.2% had an abnormal QRS interval. This 
showed that there was no significant effect of beta 
blocker usage on QRS complex abnormalities. 
The percentages of cases with QRS 
abnormalities and PR changes, however, did not 
show any trend as we go from Pugh Child Class A to 
C. The percentage of cases showing QT prolongation 
in our study (With Class A 25% to Class B 30.1% to 
Class C 41%) is slightly lower than that in already 
published data (which is 25–51 to 60 as we move 
from Pugh class A to C ), however a similar upward 
trend has been shown.5,10 
The clinical significance of the prolonged 
QT interval is still in the grey zone but in a study by 
Bernardi M et al, it was seen that survival in these 
patients with prolonged QT interval is shorter as 
compared to normal QT interval.5 The interesting 
finding in this study was that there was shorter 
survival in those who are child class A with 
prolonged QT interval while in rest of the two child 
classes are not affected for mortality by prolonged 
QT.5 From this it can clearly be concluded that 
prolonged QT interval is risk factor for mortality in 
cirrhotic patient in the earlier stage of disease.  
A limitation of our study was that the 
number of cases in the Child Pugh class A was very 
small, and that all patients using beta blockers were 
distributed among classes B and C and none in A. 
Beta-blockers have the potential to cause QT 
shortening in patients with prolonged baseline values 
due13, thus partially explaining the lowering effect in 
the percentage of patients who present with QT 
prolongation from Child classes B and C.  
We also found in our study that the 
percentage of cases with QT prolongation increases 
uniformly as we go from class A to C. This is unlike 
the findings in two previous studies13,14 which show 
that occurrence of QT prolongation in classes B and 
C is much higher than in class A. This again 
emphasizes the need for earlier intervention because 
of a higher risk in class A patients with prolonged QT 
interval in Southeast Asia compared with the rest of 
the world.   
CONCLUSION 
We conclude that QT prolongation is more frequent 
in patients with liver cirrhosis especially when the 
disease is more advanced like in Child C, although 
this difference is not statistically significant, hence 
these patients are more prone to sudden cardiac 
death. Moreover, this study shows that the risk 
associated with QT prolongation is present through 
all classes of liver cirrhosis. 
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